Lorente J, Sokolov A, Ferguson G, Schioth H, Hauser A, Gloriam D
Nat Rev Drug Discov. 2025; .
PMID: 40033110
DOI: 10.1038/s41573-025-01139-y.
Xiang Q, Tian Y, Yang K, Du Y, Xie J
Mol Med. 2025; 31(1):67.
PMID: 39972252
PMC: 11841161.
DOI: 10.1186/s10020-025-01118-4.
Brahma R, Moon S, Shin J, Cho K
J Cheminform. 2025; 17(1):12.
PMID: 39881398
PMC: 11780767.
DOI: 10.1186/s13321-024-00945-7.
Shiimura Y, Im D, Tany R, Asada H, Kise R, Kurumiya E
Nat Struct Mol Biol. 2025; .
PMID: 39833471
DOI: 10.1038/s41594-024-01481-6.
Orlans J, Rose S, Ferguson G, Oscarsson M, Homs Puron A, Beteva A
Commun Chem. 2025; 8(1):6.
PMID: 39775172
PMC: 11707155.
DOI: 10.1038/s42004-024-01404-y.
Photoswitch dissociation from a G protein-coupled receptor resolved by time-resolved serial crystallography.
Glover H, Sassmannshausen T, Bertrand Q, Trabuco M, Slavov C, Bacchin A
Nat Commun. 2024; 15(1):10837.
PMID: 39738009
PMC: 11686364.
DOI: 10.1038/s41467-024-55109-w.
USP34 regulates endothelial PAR1 mRNA transcript expression and cellular signaling.
Cheng N, Gonzalez Ramirez M, Ramirez M, Edwards C, Trejo J
Mol Biol Cell. 2024; 36(2):ar12.
PMID: 39705380
PMC: 11809309.
DOI: 10.1091/mbc.E24-07-0294.
G protein-coupled receptors: a gateway to targeting oncogenic EVs?.
Di Niro L, Linders A, Glynn T, Pegtel D, Siderius M, Crudden C
Extracell Vesicles Circ Nucl Acids. 2024; 5(2):233-248.
PMID: 39698539
PMC: 11648488.
DOI: 10.20517/evcna.2024.10.
Dopamine-conjugated extracellular vesicles induce autophagy in Parkinson's disease.
Sul J, Shin S, Kim H, Han J, Kim J, Son S
J Extracell Vesicles. 2024; 13(12):e70018.
PMID: 39641313
PMC: 11621972.
DOI: 10.1002/jev2.70018.
Leveraging Artificial Intelligence in GPCR Activation Studies: Computational Prediction Methods as Key Drivers of Knowledge.
Caniceiro A, Orzel U, Rosario-Ferreira N, Filipek S, Moreira I
Methods Mol Biol. 2024; 2870:183-220.
PMID: 39543036
DOI: 10.1007/978-1-0716-4213-9_10.
Genome-wide pan-GPCR cell libraries accelerate drug discovery.
Yang H, Wang Y, Liu W, He T, Liao J, Qian Z
Acta Pharm Sin B. 2024; 14(10):4296-4311.
PMID: 39525595
PMC: 11544303.
DOI: 10.1016/j.apsb.2024.06.023.
Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches.
Kim J, Choi C
Curr Issues Mol Biol. 2024; 46(10):11646-11664.
PMID: 39451571
PMC: 11505999.
DOI: 10.3390/cimb46100691.
Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential.
Peter S, Siragusa L, Thomas M, Palomba T, Cross S, OBoyle N
J Chem Inf Model. 2024; 64(21):8176-8192.
PMID: 39441864
PMC: 11558664.
DOI: 10.1021/acs.jcim.4c00819.
Entropy drives the ligand recognition in G-protein-coupled receptor subtypes.
Yang X, Zhou P, Shen S, Hu Q, Tian C, Xia A
Proc Natl Acad Sci U S A. 2024; 121(30):e2401091121.
PMID: 39024109
PMC: 11287286.
DOI: 10.1073/pnas.2401091121.
Conformational dynamics underlying atypical chemokine receptor 3 activation.
Otun O, Aljamous C, Del Nero E, Arimont-Segura M, Bosma R, Zarzycka B
Proc Natl Acad Sci U S A. 2024; 121(30):e2404000121.
PMID: 39008676
PMC: 11287255.
DOI: 10.1073/pnas.2404000121.
Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease.
Sangwung P, Ho J, Siddall T, Lin J, Tomas A, Jones B
Am J Physiol Endocrinol Metab. 2024; 327(5):E600-E615.
PMID: 38984948
PMC: 11559640.
DOI: 10.1152/ajpendo.00371.2023.
Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of HPrK/P.
Li S, Zhou Y, Yan Y, Qin Y, Weng Q, Sun L
Life (Basel). 2024; 14(6).
PMID: 38929642
PMC: 11204831.
DOI: 10.3390/life14060657.
A Study on the Robustness and Stability of Explainable Deep Learning in an Imbalanced Setting: The Exploration of the Conformational Space of G Protein-Coupled Receptors.
Gutierrez-Mondragon M, Vellido A, Konig C
Int J Mol Sci. 2024; 25(12).
PMID: 38928278
PMC: 11203844.
DOI: 10.3390/ijms25126572.
Revolutionizing GPCR-ligand predictions: DeepGPCR with experimental validation for high-precision drug discovery.
Zhang H, Fan H, Wang J, Hou T, Saravanan K, Xia W
Brief Bioinform. 2024; 25(4).
PMID: 38864340
PMC: 11167311.
DOI: 10.1093/bib/bbae281.
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists.
Kosar M, Sarott R, Sykes D, Viray A, Vitale R, Tomasevic N
ACS Cent Sci. 2024; 10(5):956-968.
PMID: 38799662
PMC: 11117691.
DOI: 10.1021/acscentsci.3c01461.